Literature DB >> 16936105

A common locus for late-onset Fuchs corneal dystrophy maps to 18q21.2-q21.32.

Olof H Sundin1, Karl W Broman, Howard H Chang, Elizabeth C L Vito, Walter J Stark, John D Gottsch.   

Abstract

PURPOSE: To identify the genetic basis of late-onset Fuchs corneal dystrophy (FCD).
METHODS: Phenotypes and genotypes at 1107 short tandem repeat polymorphism markers were obtained for 43 affected and 33 unaffected individuals in three large families. Two-point genetic linkage analysis was performed with MLINK and multipoint linkage with SimWalk 2.89.
RESULTS: In each family, the most significant cluster of two-point lod scores mapped to chromosome 18, at 18q21.2-q21.3. The highest two-point lod score for each family was at D18S1129, with scores of 3.41, 2.89, and 2.45, with a combined two-point lod score of 7.70. Multipoint analysis yielded a maximum score of 5.94 at D18S1129 for a dominant Mendelian trait exhibiting 85% penetrance and 15% phenocopy rate. Disease interval haplotypes for each family are different.
CONCLUSIONS: FCD2, at 18q21, is the second genetic locus identified for late-onset FCD. Presence of this same locus in all three families may indicate its widespread involvement in late-onset FCD. Allelic differences between disease-associated haplotypes in the families leave open the possibility of independent mutations in the same gene. The incomplete penetrance and high phenocopy rate observed at FCD2 suggest that the origin of FCD in these three families is complex and also depends on other genetic loci or environmental factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16936105     DOI: 10.1167/iovs.05-1619

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  49 in total

1.  Mutations in AGBL1 cause dominant late-onset Fuchs corneal dystrophy and alter protein-protein interaction with TCF4.

Authors:  S Amer Riazuddin; Shivakumar Vasanth; Nicholas Katsanis; John D Gottsch
Journal:  Am J Hum Genet       Date:  2013-10-03       Impact factor: 11.025

Review 2.  Molecular bases of corneal endothelial dystrophies.

Authors:  Thore Schmedt; Mariana Mazzini Silva; Alireza Ziaei; Ula Jurkunas
Journal:  Exp Eye Res       Date:  2011-08-10       Impact factor: 3.467

3.  TCF4 Triplet Repeat Expansion and Nuclear RNA Foci in Fuchs' Endothelial Corneal Dystrophy.

Authors:  V Vinod Mootha; Imran Hussain; Khrishen Cunnusamy; Eric Graham; Xin Gong; Sudha Neelam; Chao Xing; Ralf Kittler; W Matthew Petroll
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-02-26       Impact factor: 4.799

Review 4.  The Molecular Basis of Fuchs' Endothelial Corneal Dystrophy.

Authors:  Jie Zhang; Charles N J McGhee; Dipika V Patel
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

5.  Fuchs' corneal dystrophy.

Authors:  Allen O Eghrari; John D Gottsch
Journal:  Expert Rev Ophthalmol       Date:  2010-04

6.  CTG18.1 Expansion in TCF4 Increases Likelihood of Transplantation in Fuchs Corneal Dystrophy.

Authors:  Allen O Eghrari; Shivakumar Vasanth; Jiangxia Wang; Farnoosh Vahedi; S Amer Riazuddin; John D Gottsch
Journal:  Cornea       Date:  2017-01       Impact factor: 2.651

7.  Immunohistochemistry and electron microscopy of early-onset fuchs corneal dystrophy in three cases with the same L450W COL8A2 mutation.

Authors:  Cheng Zhang; W Robert Bell; Olof H Sundin; Zenaida De La Cruz; Walter J Stark; W Richard Green; John D Gottsch
Journal:  Trans Am Ophthalmol Soc       Date:  2006

8.  The genetics of Fuchs' corneal dystrophy.

Authors:  Benjamin W Iliff; S Amer Riazuddin; John D Gottsch
Journal:  Expert Rev Ophthalmol       Date:  2012-08

9.  Genetic analysis of patients with Fuchs endothelial corneal dystrophy in India.

Authors:  Boomiraj Hemadevi; Muthiah Srinivasan; Jambulingam Arunkumar; Namperumalsamy V Prajna; Periasamy Sundaresan
Journal:  BMC Ophthalmol       Date:  2010-02-10       Impact factor: 2.209

Review 10.  Corneal dystrophies.

Authors:  Gordon K Klintworth
Journal:  Orphanet J Rare Dis       Date:  2009-02-23       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.